Ano Kaisha no Shikumi
Search
Menu

Japan Tissue Engineering

Japan Tissue Engineering Co., Ltd.

Company highlights

The largest segment by revenue is 再生医療製品事業, at 62.1% of the total.

Key figures

Period Apr 2025 to Mar 2026Parent onlyJapanese GAAP

RevenueDisclosed ¥2.2B
Operating marginCalculated -25.2%
Net assets to total assetsCalculated 89.6%

Company profile

Securities code 7774 / EDINET code E02357 / Precision Instruments / Fiscal year end March 31

蒲郡市三谷北通６丁目２０９番地の１／Capital stock ¥3,997 million
Address, capital stock, fiscal year end and industry: the FSA’s EDINET code list.

Company details
社長執行役員山田一登 Representative

Tables scroll sideways

Disclosed data

Source: Annual Securities Report (Apr 2025 to Mar 2026) · filed 2026-06-18

Profitability ★☆☆☆☆position among all companies -25.2%
Growth (revenue, 4-year average) ★☆☆☆☆position among all companies 0.9%
Capital efficiency Could not be retrieved

Business activities and revenue composition

Japan Tissue Engineering

Revenue and profit by business segment

Period Apr 2025 to Mar 2026Source Annual securities reportsParent only・Disclosed

SalesProfit 再生医療製品事業再生医療製品事業 Sales 62.1% 62% Profit 17.1% 17% 再生医療受託事業再生医療受託事業 Sales 25.0% 25% Profit 71.4% 71% ラボサイト事業ラボサイト事業 Sales 12.9% 13% Profit 11.5% 12%
BusinessNet sales to external customers Operating income
This yearShareLast year This yearShareMarginLast year
再生医療製品事業 ¥1.4 billion 62.1% ¥1.5 billion ¥78.30 million 17.1% 5.8% ¥0.2 billion
再生医療受託事業 ¥0.5 billion 25.0% ¥0.7 billion ¥0.3 billion 71.4% 59.9% ¥0.4 billion
ラボサイト事業 ¥0.3 billion 12.9% ¥0.2 billion ¥52.77 million 11.5% 18.7% ¥67.51 million
Total of the businesses ¥2.2 billion100.0% ¥0.5 billion 100.0%

Revenue and profit

Japan Tissue Engineering

Period Apr 2025 to Mar 2026Source Annual securities reports

Net sales and operating revenue ¥2.2B　100% Cost of sales ¥0.9B　42% Selling, general and administrative expenses ¥1.8B　83% Operating income ¥-0.5B　25%
Amounts by account
GroupAccountAmountConsolidated / Non-consolidated
Selling, general and administrative expenses Personnel expenses ¥0.8 billion Parent only
Research and development expenses ¥0.5 billion Parent only
Other ¥0.4 billion Parent only
Commission fees ¥71.31 million Parent only
Taxes and dues ¥42.19 million Parent only
Depreciation ¥41.21 million Parent only
Rents ¥18.64 million Parent only
Supplies expenses ¥16.32 million Parent only
Donations ¥0.07 million Parent only
Profit by stage Gross profit (loss) ¥1.3 billion Parent only
Operating income ¥-0.5 billion Parent only
Ordinary income ¥-0.5 billion Parent only

Japan Tissue Engineering

Selling, general and administrative expenses

Period Apr 2025 to Mar 2026Source Annual securities reports

Personnel expenses ¥0.8 billion (42.3%)42%Research and development expenses ¥0.5 billion (27.4%)27%Other ¥0.4 billion (19.9%)20%Commission fees ¥0.1 billion (3.9%)Taxes and dues ¥0.0 billion (2.3%)Depreciation ¥0.0 billion (2.3%)Other (not itemized) ¥0.0 billion (1.9%)¥1.8B
  • Personnel expenses　¥0.8 billion
  • Research and development expenses　¥0.5 billion
  • Other　¥0.4 billion
  • Commission fees　¥0.1 billion
  • Taxes and dues　¥0.0 billion
  • Depreciation　¥0.0 billion
  • Other (not itemized)　¥0.0 billion

Performance, financial position and capital allocation

Finance
89.6% Net assets to total assets Industry median 68.5% FY ending 3/2026 · consolidated / calculated
¥125.35 Net assets per share
¥5.7 billion Total assets

Long-term changes in performance

Period 2013 to 2026Disclosed

Revenue ×3.87 from 2013 to 2026

Japan Tissue Engineering

Long-term revenue, profit and asset trends

Period 2013 to 2026Source Annual securities reportsDisclosed

Mark on the chart
3 1 0 -1 2013 2015 2017 2019 2021 2023 2025 2026 Net sales and operating revenue Ordinary income 2014　Net sales year on year +78.8%, Ordinary income (loss) as a share of revenue +108.8 points 2015　Net sales year on year +31.1%, Ordinary income (loss) as a share of revenue +29.8 points 2016　Ordinary income (loss) as a share of revenue +4.6 points 2017　Net sales year on year +49.2%, Ordinary income (loss) as a share of revenue +61.9 points, Ordinary income (loss) loss to profit 2018　Ordinary income (loss) as a share of revenue -5.1 points 2019　Ordinary income (loss) as a share of revenue -23.8 points, Ordinary income (loss) profit to loss 2020　Ordinary income (loss) as a share of revenue +4.5 points 2021　Ordinary income (loss) as a share of revenue -10.6 points 2022　Ordinary income (loss) as a share of revenue -3.0 points 2023　Ordinary income (loss) as a share of revenue -12.2 points 2024　Net sales year on year +23.7%, Ordinary income (loss) as a share of revenue +41.5 points, Ordinary income (loss) loss to profit 2025　Ordinary income (loss) as a share of revenue -15.4 points, Ordinary income (loss) profit to loss 2026　Ordinary income (loss) as a share of revenue -15.1 points 2Latest value 2026 2¥ billion 3Highest in the period shown 2024 3¥ billion 1Lowest in the period shown 2013 1¥ billion ¥ billion

Japan Tissue Engineering

Recent performance trends

Source Annual securities reports

3 1 0 -1 4 years ago 3 years ago 2 years ago Last year This year Net sales and operating revenue Ordinary income ¥ billion

Year-on-year comparison

Period 2013 to 2026Disclosed

Item20222023202420252026
Net sales ¥2.1B ¥2.0B ¥2.5B ¥2.5B ¥2.2B
Year on year (%) -6.8% -3.4% +23.7%◆ -2.3% -11.1%
Ordinary income (loss) -¥0.5B -¥0.7B ¥0.1B -¥0.2B -¥0.5B
Change from prior year 1.07x 1.47x loss to profit◆ profit to loss◆ 2.29x
Ordinary income (loss) as a share of Net sales -23.5% -35.7% 5.8% -9.5% -24.6%
Change (percentage points) -3.0 points◆ -12.2 points◆ +41.5 points◆ -15.4 points◆ -15.1 points◆

Fiscal periods marked for changes

Earlier fiscal periods (10)
  • 2014Net sales year on year +78.8%, Ordinary income (loss) as a share of revenue +108.8 points
  • 2015Net sales year on year +31.1%, Ordinary income (loss) as a share of revenue +29.8 points
  • 2016Ordinary income (loss) as a share of revenue +4.6 points
  • 2017Net sales year on year +49.2%, Ordinary income (loss) as a share of revenue +61.9 points, Ordinary income (loss) loss to profit
  • 2018Ordinary income (loss) as a share of revenue -5.1 points
  • 2019Ordinary income (loss) as a share of revenue -23.8 points, Ordinary income (loss) profit to loss
  • 2020Ordinary income (loss) as a share of revenue +4.5 points
  • 2021Ordinary income (loss) as a share of revenue -10.6 points
  • 2022Ordinary income (loss) as a share of revenue -3.0 points
  • 2023Ordinary income (loss) as a share of revenue -12.2 points
  • 2024Net sales year on year +23.7%, Ordinary income (loss) as a share of revenue +41.5 points, Ordinary income (loss) loss to profit
  • 2025Ordinary income (loss) as a share of revenue -15.4 points, Ordinary income (loss) profit to loss
  • 2026Ordinary income (loss) as a share of revenue -15.1 points

Japan Tissue Engineering

Earnings and net assets per share over time

Unit yenSource Annual securities reports

4 -4 -11 -18 4 years ago 3 years ago 2 years ago Last year This year Earnings per share yen 164 109 55 0 4 years ago 3 years ago 2 years ago Last year This year Net assets per share yen
Parent only indicators (15 items)
Item4 years ago3 years ago2 years agoLast yearThis year
Net sales ¥2.1 billion ¥2.0 billion ¥2.5 billion ¥2.5 billion ¥2.2 billion
Ordinary income (loss) ¥-0.5 billion ¥-0.7 billion ¥0.1 billion ¥-0.2 billion ¥-0.5 billion
Net income (loss) ¥-0.5 billion ¥-0.7 billion ¥0.1 billion ¥-0.3 billion ¥-0.7 billion
Capital stock ¥5.0 billion ¥5.0 billion ¥5.0 billion ¥5.0 billion ¥4.0 billion
Total number of issued shares (common stock) 40,610,200 shares 40,610,200 shares 40,610,200 shares 40,610,200 shares 40,610,200 shares
Net assets ¥6.7 billion ¥5.9 billion ¥6.1 billion ¥5.8 billion ¥5.1 billion
Total assets ¥7.6 billion ¥6.9 billion ¥7.0 billion ¥6.5 billion ¥5.7 billion
Net assets per share 164.16 yen 146.2 yen 149.73 yen 143.44 yen 125.35 yen
Basic earnings (loss) per share -12.26 yen -17.96 yen 3.53 yen -6.29 yen -18.09 yen
Equity-to-asset ratio 87.7% 86.3% 87.0% 89.4% 89.6%
Return on equity Could not be retrieved Could not be retrieved 2.4% Could not be retrieved Could not be retrieved
Net cash provided by (used in) operating activities ¥-0.2 billion ¥-0.6 billion ¥0.3 billion ¥-0.1 billion ¥-0.5 billion
Net cash provided by (used in) investing activities ¥-0.1 billion ¥1.1 billion ¥-0.2 billion ¥-0.2 billion ¥0.3 billion
Net cash provided by (used in) financing activities ¥-0.82 million ¥-0.80 million ¥-0.13 million ¥-3,000 Could not be retrieved
Cash and cash equivalents ¥1.5 billion ¥2.0 billion ¥2.1 billion ¥1.7 billion ¥1.5 billion

Shareholder composition

As of 2026-03-31Disclosed

Share ownership by holder category

11,353 Shareholders
1.37% Foreign holders (total) Industry median 15.54%
28.56% Individuals and others Industry median 36.26%

Japan Tissue Engineering

Unit %Source Annual securities reports

  • Financial institutions0.01%
  • Securities firms0.44%
  • Other corporations69.60%
  • Foreign holders (institutions)1.31%
  • Foreign holders (individuals)0.06%
  • Individuals and others28.56%

Major shareholders

RankShareholderShareholding ratioShares held
1 帝人株式会社 57.71% 23,439,173
2 株式会社ニデック 10.4% 4,227,200
3 前田 陽子 0.84% 342,400
4 五味 大輔 0.81% 330,000
5 小澤 洋介 0.71% 292,000
6 J-TEC従業員持株会 0.6% 244,889
7 サーラエナジー株式会社 0.45% 184,000
8 上田八木短資株式会社 0.36% 149,500
9 楽天証券株式会社 0.34% 138,400
10 BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)PETERBOROUGH COURT 133 FLEET STREET 0.28% 115,164

Research and development expenses and capital expenditure

Source: R&D and capital expenditure sections, annual securities reports · 2 years (2021 to 2026)Disclosed

¥0.5 billion Research and development
¥70.71 million Capital expenditure
Fiscal year Research and development Capital expenditure
FY ending 3/2026 ¥0.5 billion ¥70.71 million
FY ending 3/2021 ¥0.5 billion ¥68.52 million

Revenue scale in the same industry

Japan Tissue Engineering

Source Annual securities reports of each company

Precision Instruments: 54 companies · revenue · largest first・each company’s latest fiscal year・consolidated (parent-only where no consolidated figures)・Disclosed

  • 1 TERUMOFY Mar 2026 ¥1.1T
  • 2 OLYMPUSFY Mar 2026 ¥1.0T
  • 3 NIKONFY Mar 2026 ¥677.2B
  • … 46 companies
  • 50 CYBERDYNEFY Mar 2026 ¥3.8B
  • 51 TOYOKOHFY Mar 2026 ¥3.1B
  • 52 Japan Tissue EngineeringThis companyFY Mar 2026 ¥2.2B
  • 53 KUBOTEKFY Mar 2026 ¥2.1B
  • 54 CellSeedFY Dec 2025 ¥83,678,000

Workforce information

Source: Annual Securities Report (Apr 2025 to Mar 2026)Parent-onlyDisclosed

200 Employees (parent only) Industry median 392
39.7 Average age Industry median 43.2
12.0 years Average length of service Industry median 13.1 years
¥6.11 million Average annual salary Industry median ¥6.90 million
People and organisation
10.9¥ million Sales per employee Industry median 32.6¥ million FY ending 3/2026 · parent company only / calculated
¥-2.75 million Operating income per employee
76.6% Wage gap between men and women
36.4% Women in managerial positions
78.0% Share of female employees
100.0% Men taking childcare leave
16 / 44 Female managers
0 / 6 Female officers
23 Average temporary staff

Administrative filings and published information

Workplace information filings

Filed 2026-05-28Disclosed

ItemValue
Employees 228
Average monthly overtime (statutory overtime plus work on statutory days off)
Scope: 正社員		 8.4 hours
Annual paid leave taken
Scope: その他		 82%
Childcare leave taken, men
Scope: その他		 100%
Childcare leave taken, women
Scope: その他		 100%
Share of managers who are women 36.4%
Share of board members who are women 0%

Audit and disclosure information

Annual securities report, year ended 2026-03-31Disclosed

ItemValue
Audit firm 有限責任あずさ監査法人
Audit fees (this year, filing company) ¥20.86 million
Non-audit fees (this year, total) Not applicable
Going concern note Cannot be determined
Accounting standard Japanese GAAP

See the book series →

Sources and methodology

Retrieved disclosed figures

Accounts and values from the annual securities report, by section

Major management indicators (5 years) (13 items)

ItemValueConsolidated / Non-consolidated
Net cash provided by (used in) operating activities ¥-0.5 billion Parent only
Net sales ¥2.2 billion Parent only
Net income (loss) ¥-0.7 billion Parent only
Net cash provided by (used in) investing activities ¥0.3 billion Parent only
Cash and cash equivalents ¥1.5 billion Parent only
Total number of issued shares (common stock) 40,610,200 shares Parent only
Net assets ¥5.1 billion Parent only
Ordinary income (loss) ¥-0.5 billion Parent only
Total assets ¥5.7 billion Parent only
Equity-to-asset ratio 89.6% Parent only
Capital stock ¥4.0 billion Parent only
Basic earnings (loss) per share -18.09 yen Parent only
Net assets per share 125.35 yen Parent only

Employees (9 items)

ItemValueConsolidated / Non-consolidated
Wage gap between men and women (all employees) 76.6% Parent only
Average length of service (years) 12 years Parent only
Average annual salary ¥6.11 million Parent only
Average age (years) 39.7 years old Parent only
Number of employees 200 people Parent only
Number of employees 200 people Parent only
Number of employees 200 people Parent only
Wage gap between men and women (regular employees) 77.9% Parent only
Wage gap between men and women (non-regular employees) 43.0% Parent only

Other disclosed items (9 items)

ItemValueConsolidated / Non-consolidated
Rate of male employees taking childcare leave (all employees) 100.0% Parent only
Net sales to external customers ¥2.2 billion Parent only
Average number of temporary employees 23 people Parent only
Average number of temporary employees 23 people Parent only
Average number of temporary employees 23 people Parent only
Increase in property plant and equipment and intangible assets ¥70.71 million Parent only
Total return on the share price index 179.0% Parent only
Depreciation ¥0.2 billion Parent only
Ratio of female employees in managerial positions 36.4% Parent only

Shares (12 items)

ItemValueConsolidated / Non-consolidated
Number of shares held 29,462,726 shares Consolidated
Total number of shares held treasury shares etc 200 shares Consolidated
Number of issues whose number of shares increased shares not listed investment shares held for purposes other than pure investment reporting company 1 issues Consolidated
Total acquisition cost for increased shares shares not listed investment shares held for purposes other than pure investment reporting company ¥0.1 billion Consolidated
Number of shares 40,610,200 shares Consolidated
Shareholding ratio treasury shares etc 0.0% Consolidated
Shareholding ratio 72.5% Consolidated
Number of shares held in own name treasury shares etc 200 shares Consolidated
Number of voting rights 405,932 units Consolidated
Carrying amount on the balance sheet ¥0.1 billion Consolidated
Number of issues 1 issues Consolidated
Total shareholder return 78.9% Parent only

Research and development (1 items)

ItemValueConsolidated / Non-consolidated
Research and development expenses ¥0.5 billion Consolidated

Property and facilities (1 items)

ItemValueConsolidated / Non-consolidated
Capital expenditures ¥70.71 million Consolidated

Audit (1 items)

ItemValueConsolidated / Non-consolidated
Fees for audit and attestation services - reporting company ¥20.86 million Consolidated

Accounts unique to this company (4 items)

ItemValueConsolidated / Non-consolidated
Change in average annual salary from the previous year -0.2% Parent only
Revenue ¥0.6 billion Parent only
Revenue ¥0.2 billion Parent only
Revenue ¥0.1 billion Parent only

Balance sheet (61 items)

ItemValueConsolidated / Non-consolidated
Other ¥1.99 million Parent only
Other ¥85.80 million Parent only
Other ¥0.1 billion Parent only
Other ¥20.36 million Parent only
Software ¥29.68 million Parent only
Work in process ¥20.28 million Parent only
Investments in capital ¥0.02 million Parent only
Retained earnings ¥-0.7 billion Parent only
Prepaid expenses ¥28.60 million Parent only
Raw materials and supplies ¥0.2 billion Parent only
Merchandise and finished goods ¥0.21 million Parent only
Non-current liabilities ¥32.20 million Parent only
Non-current assets ¥1.5 billion Parent only
Land ¥0.6 billion Parent only
Accounts receivable - trade ¥0.5 billion Parent only
Contract liabilities ¥23.73 million Parent only
Tools, furniture and fixtures ¥0.4 billion Parent only
Tools, furniture and fixtures ¥45.08 million Parent only
Buildings ¥2.0 billion Parent only
Buildings, net ¥0.5 billion Parent only
Construction in progress ¥41.13 million Parent only
Provision for directors' bonuses ¥0.45 million Parent only
Provision for directors' retirement benefits ¥30.00 million Parent only
Investments and other assets ¥0.1 billion Parent only
Investment securities ¥0.1 billion Parent only
Property, plant and equipment ¥1.3 billion Parent only
Income taxes payable ¥12.84 million Parent only
Accrued expenses ¥19.94 million Parent only
Accounts payable - other ¥0.2 billion Parent only
Shareholders' equity ¥5.1 billion Parent only
Structures ¥20.38 million Parent only
Structures, net ¥1.34 million Parent only
Machinery and equipment ¥0.6 billion Parent only
Machinery and equipment, net ¥0.1 billion Parent only
Current liabilities ¥0.6 billion Parent only
Current assets ¥4.2 billion Parent only
Accumulated depreciation ¥-0.4 billion Parent only
Accumulated depreciation ¥-1.5 billion Parent only
Accumulated depreciation ¥-19.04 million Parent only
Accumulated depreciation ¥-0.4 billion Parent only
Intangible assets ¥50.05 million Parent only
Cash and cash equivalents ¥1.5 billion Parent only
Cash and deposits ¥3.3 billion Parent only
Net assets ¥5.1 billion Parent only
Net assets ¥5.1 billion Parent only
Total assets ¥5.7 billion Parent only
Total assets ¥5.7 billion Parent only
Retained earnings brought forward ¥-0.7 billion Parent only
Treasury stock ¥-0.31 million Parent only
Liabilities ¥0.6 billion Parent only
Liabilities and net assets ¥5.7 billion Parent only
Accounts payable - trade ¥27.56 million Parent only
Capital surplus ¥1.8 billion Parent only
Legal capital surplus ¥1.8 billion Parent only
Capital stock ¥4.0 billion Parent only
Provision for bonuses ¥0.1 billion Parent only
Provision for retirement benefits ¥2.20 million Parent only
Long-term prepaid expenses ¥12.02 million Parent only
Electronically recorded obligations - operating ¥79.33 million Parent only
Electronically recorded monetary claims - operating ¥33.92 million Parent only
Deposits received ¥9.01 million Parent only

Statement of income (47 items)

ItemValueConsolidated / Non-consolidated
Other ¥0.4 billion Parent only
Personnel expenses ¥0.8 billion Parent only
Transfer to other accounts ¥2.82 million Parent only
Interest income ¥9.78 million Parent only
Dividend income ¥0 Parent only
Total ¥0.7 billion Parent only
Cost of merchandise and finished goods sold ¥0.7 billion Parent only
Net sales of merchandise and finished goods ¥1.6 billion Parent only
Ending merchandise and finished goods ¥0.21 million Parent only
Beginning merchandise and finished goods ¥1.93 million Parent only
Operating income ¥-0.5 billion Parent only
Operating income ¥-0.5 billion Parent only
Non-operating income ¥13.67 million Parent only
Non-operating expenses ¥1.67 million Parent only
Net cash provided by (used in) operating activities ¥-0.5 billion Parent only
Loss on tax purpose reduction entry of non-current assets ¥31.82 million Parent only
Loss on retirement of non-current assets ¥43.33 million Parent only
Rents ¥18.64 million Parent only
Cost of sales ¥0.9 billion Parent only
Gross profit (loss) ¥1.3 billion Parent only
Net sales ¥2.2 billion Parent only
Net sales ¥2.2 billion Parent only
Donations ¥0.07 million Parent only
Net income (loss) ¥-0.7 billion Parent only
Net income (loss) ¥-0.7 billion Parent only
Cost of products manufactured ¥0.7 billion Parent only
Loss on valuation of investment securities ¥0.1 billion Parent only
Net cash provided by (used in) investing activities ¥0.3 billion Parent only
Commission fees ¥71.31 million Parent only
Income taxes - current ¥3.98 million Parent only
Income taxes ¥3.98 million Parent only
Supplies expenses ¥16.32 million Parent only
Depreciation ¥41.21 million Parent only
Foreign exchange losses ¥0.46 million Parent only
Extraordinary income ¥31.82 million Parent only
Extraordinary loss ¥0.2 billion Parent only
Effect of exchange rate change on cash and cash equivalents ¥-0 Parent only
Net increase (decrease) in cash and cash equivalents ¥-0.2 billion Parent only
Research and development expenses ¥0.5 billion Parent only
Taxes and dues ¥42.19 million Parent only
Income (loss) before income taxes ¥-0.7 billion Parent only
Income (loss) before income taxes ¥-0.7 billion Parent only
Ordinary income ¥-0.5 billion Parent only
Subsidy income ¥31.82 million Parent only
Selling, general and administrative expenses ¥1.8 billion Parent only
Miscellaneous income ¥3.88 million Parent only
Other ¥1.21 million Parent only

Statement of changes in equity (1 items)

ItemValueConsolidated / Non-consolidated
Total changes during the period ¥-0.7 billion Parent only

Statement of cash flows (25 items)

ItemValueConsolidated / Non-consolidated
Other ¥5.64 million Parent only
Other ¥-1.08 million Parent only
Increase decrease in notes and accounts payable trade ¥-2.38 million Parent only
Interest and dividends income received ¥9.85 million Parent only
Interest and dividend income ¥-9.78 million Parent only
Loss on tax purpose reduction entry of non-current assets ¥31.82 million Parent only
Loss on retirement of non-current assets ¥43.33 million Parent only
Decrease increase in notes and accounts receivable trade ¥47.61 million Parent only
Proceeds from withdrawal of time deposits ¥2.2 billion Parent only
Payments into time deposits ¥-1.8 billion Parent only
Subtotal ¥-0.5 billion Parent only
Increase decrease in provision for directors bonuses ¥-2.95 million Parent only
Increase decrease in provision for directors retirement benefits ¥-16.00 million Parent only
Purchase of investment securities ¥-0.1 billion Parent only
Purchase of property plant and equipment ¥-74.65 million Parent only
Decrease in consumption taxes payable ¥-69.15 million Parent only
Increase (decrease) in accounts payable-other ¥-12.88 million Parent only
Decrease (increase) in inventories ¥-53.50 million Parent only
Income taxes refund (paid) ¥1.05 million Parent only
Depreciation ¥0.2 billion Parent only
Purchase of intangible assets ¥-3.05 million Parent only
Proceeds from subsidy-InvCF ¥31.82 million Parent only
Subsidy income ¥-31.82 million Parent only
Increase (decrease) in provision for bonuses ¥-2.95 million Parent only
Accrued pension cost ¥-2.52 million Parent only
Basic indicators
ItemValueConsolidated / Non-consolidatedSource
Net cash provided by (used in) operating activities ¥-0.5 billion Parent onlyDisclosed
Number of employees 200 Parent onlyDisclosed
Net assets ¥5.1 billion Parent onlyDisclosed
Net sales ¥2.2 billion Parent onlyDisclosed
Operating income ¥-0.5 billion Parent onlyDisclosed
Ordinary income ¥-0.5 billion Parent onlyDisclosed
Total assets ¥5.7 billion Parent onlyDisclosed
Operating margin -25.2%Parent onlyCalculated
Net margin Not disclosedNot applicableNot calculated (a required value is not disclosed)
Sales per employee 10913725 yenParent onlyCalculated
Total asset turnover 0.38 timesParent onlyCalculated
Net assets to total assets 89.6%Parent onlyCalculated
How to read the figures, and caveats

Terms

  • Consolidated: the parent company together with the subsidiaries it consolidates
  • Parent-only: the single company that filed the annual securities report
  • Calculated: a disclosed figure put through the formula shown
  • Not disclosed: no such value in the filing (not treated as zero)
  • Not retrieved: a value this page could not extract, including values in the filing that could not be matched. The same item may appear in another table
  • Segment: a business division the company uses in its disclosures
  • Industry median: the middle value among companies in the same industry that disclose the item
  • ★: position when every company is lined up by value (not a judgement of the company)See the formulas
  • Source: document name, period covered, filing date and where it was obtained
  • Tables scroll sideways

Key figures

  • Operating margin -25.2%　Operating income ÷ net sales 　＝ ¥-0.5 billion ÷ ¥2.2 billion
    Operating income ÷ net sales. The denominator is Net sales (Parent only, Japanese GAAP).
  • Sales per employee 10,913,725 yen　Sales or operating revenue ÷ employees 　＝ ¥2.2 billion ÷ 200 people
    Sales or operating revenue ÷ employees. The denominator is Number of employees (Parent only, Japanese GAAP).
  • Total asset turnover 0.38 times　Sales or operating revenue ÷ total assets 　＝ ¥2.2 billion ÷ ¥5.7 billion
    Sales or operating revenue ÷ total assets. The denominator is Total assets (Parent only, Japanese GAAP).
  • Net assets to total assets 89.6%　Net assets ÷ total assets 　＝ ¥5.1 billion ÷ ¥5.7 billion
    Net assets ÷ total assets. The denominator is Total assets (Parent only, Japanese GAAP).

Company details

  • Representative　Representative Director, gBizINFO

Revenue and profit by business segment

  • Source: segment information, Annual Securities Report (Apr 2025 to Mar 2026) · Parent only · Net sales to external customers · filed 2026-06-18
  • Share: against the total of Net sales to external customers disclosed by business (100%). Adjustments, corporate, eliminations and “other” left out as they are not businesses (so no match with company-wide Net sales to external customers). Margin: calculated against the Net sales to external customers on the same row“報告セグメント計” in the segment information of the annual securities report: ¥2.2 billion. Gap against this table’s total (the part not listed as a business, such as “other”) within 1%The account may differ from “Revenue” at the top of this page

Amounts by account

  • Totals and their component lines together; consolidated and parent-only figures mixed (right-hand column)

Selling, general and administrative expenses

  • Breakdown of selling, general and administrative expenses (costs of selling and running the company). Cost of sales not included
  • Each item: already inside the SG&A total (not added to it)

Finance

  • Net assets to total assets　Net assets ÷ total assets
  • Net assets per share　Parent only
  • Total assets　Parent only

Long-term changes in performance

  • Revenue　Disclosed value for 2026 ÷ disclosed value for 2013

Year-on-year comparison

  • Year on year: calculated only where the item, reporting range and accounting standard match and the periods are consecutive
  • Comparison basis not confirmed: periods with a change of accounting standard or reporting range, a moved fiscal year end, or an unconfirmed period
  • ◆: a period where revenue moved 20% or more from the prior year, profit as a share of revenue moved 2.0 percentage points or more, or profit or loss changed sign. Item used named in the table and list. Not a ranking of companies

Earnings and net assets per share over time

  • Earnings per share = net profit ÷ shares; net assets per share = net assets ÷ shares. Disclosed values from the key financial indicators of the annual securities report. No share prices used

Share ownership by holder category

  • Source: ownership table, annual securities report. Percentages as disclosed, calculated on trading units (some companies do not total exactly 100%). Foreign holders (total): institutions and individuals combined. “Individuals and others”: a register category (not necessarily the share actually held by individuals). Industry median: the middle value among companies in Precision Instruments that disclose the item (industries with at least 5 companies only).

Major shareholders

  • Source: major shareholders table, annual securities report. Trust bank holdings as written (whose trust is not disclosed)

Research and development expenses and capital expenditure

  • Research and development: total in the R&D section of the annual securities report. Capital expenditure: this year’s actual spending in the capital expenditure overview (not a plan). Years: only those available in the annual securities reports on hand (one to four per company); no row for other years.

Revenue scale in the same industry

  • Revenue (disclosed values) of companies in the same industry, using the same grouping as the industry pages. Only the top three and the two companies either side of this one. Bar length relative to the largest company (100). An order of size, not a ranking of quality

Workforce information

  • All four: the reporting company (parent-only), as disclosed in the employee section of the annual securities report. Industry median: the middle value among companies in Precision Instruments that disclose the item (industries with at least 5 companies only).

People and organisation

  • Sales per employee　Net sales (or operating revenue) ÷ employees
  • Operating income per employee　Operating income ÷ employees
  • Wage gap between men and women　Women's pay with men's pay set to 100, reporting company
  • Women in managerial positions　Reporting company (parent only)
  • Share of female employees　gBizINFO, covering 正社員
  • Men taking childcare leave　Reporting company (parent only)
  • Female managers　gBizINFO: 16 women among 44 managers
  • Female officers　gBizINFO: 0 women among 6 officers
  • Average temporary staff　Parent only, average headcount other than regular employees

Workplace information filings

  • Source: processed from Shokuba-labo, the workplace information site of the Ministry of Health, Labour and Welfare. Items the company filed only Shokuba-labo

Audit and disclosure information

  • Whether there is a going concern note (the accounting assumption that a company will continue operating), and audit information
  • Audit firm, audit fees, going concern note and accounting standard: facts written in the latest annual securities report and the audit report filed with it (not a judgement of the company). Going concern note: “note” when the note text is present, “not applicable” when the report states nothing to report, “cannot be determined” when neither appears. Note text not reproduced. Amended filings not shown (annual securities reports only)

Data sources and calculation methods

Primary source: the annual securities report of Japan Tissue Engineering Co., Ltd. on EDINET, the FSA’s disclosure system (free to read)
Corporate number: 4180301011063 / Accounting standard: Japanese GAAP

  • Amounts: machine transcription of EDINET XBRL (no manual re-keying). Long narrative notes are text and not in the account list. Identifiers: machine transcription of the EDINET code list (retrieved 2026-08-22)
  • ★: position of the value calculated from disclosed figures among the 4,240 companies on this site, on a five-step scale. Not a judgement of the company. No forecasts usedThe formulas and how they are counted
  • No rank: net assets as a share of total assets, cash conversion and revenue per employee (size alone does not show quality). Industry median shown for comparison. Cash conversion of 100%: operating cash flow equal to operating profit
  • Profit-and-loss chart: only where “sales − cost of sales − SG&A = operating income” holds between disclosed values. Cost breakdown: the six largest SG&A items
  • Trend charts: key financial indicators of the annual securities report. Amounts in billions of yen (dividend per share in yen). Long-run chart joins reports filed in different years (newer report for overlapping years). Some items stop part-way after a change of accounting standard. A stock split changes the weight of one share. Consolidated and parent-only in separate tables
  • Revenue scale in the same industry: bars of revenue (disclosed values) of companies in the same industry grouping as the industry pages, largest first. Only the top three and the two companies either side of this one. Each company’s latest fiscal year. An order of size, not a ranking of quality or an investment view
  • Share prices: not published (no data source allows redistribution). No share-price-based indicators (such as the price earnings ratio) and no extension of past growth into the future
  • Average age, average length of service and average annual salary: the reporting company alone (the parent). At a holding company, a small head-office staff. Payout ratio (basic facts): dividend per share ÷ consolidated earnings per share, calculated here (the payout ratio in the annual securities report is the reporting company’s figure, on a different basis). Representative and founding date: gBizINFO (Ministry of Economy, Trade and Industry), some companies only
  • “Retrieved disclosed figures”: every value readable as a number from the annual securities report. Company-wide values only (no segment or other breakdowns)
  • Segment table: machine transcription of the segment information in the annual securities report. Business names as labelled by the company in its XBRL. No table where segment sales differ from the disclosed total by more than 1%. Adjustments, corporate, eliminations and “other” left out of the table and the share denominator, as they are not businesses
  • Breakdowns of amounts, not diagrams of how the business works. Who pays whom, and for what, is not in the disclosed figures; no lines drawn from guesswork